Trade Summary

2 days ago, Leonard Frank X, serving as Chief Executive Officer at NovoCure Ltd (NVCR), sold 34,273 shares at $17.93 per share, for a total transaction value of $614,634.85. Following this transaction, Leonard Frank X now holds 459,520 shares of NVCR.

This sale represents a 6.94% decrease in Leonard Frank X's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, June 4, 2026 and publicly disclosed via SEC Form 4 filing on Friday, June 5, 2026 at 4:28 PM ET, 1 day after the trade was made.

NovoCure Ltd operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.